Treatment of Hypercholesterolemia by Interference With Bile Acid Metabolism

Archives of Internal Medicine

Volumn 130, Issue 4, 1972, Pages 638-648

  Grundy, Scott M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLESTEROL; COLESTYRAMINE;

BLOOD; HYPERCHOLESTEROLEMIA; ILEUM; LIGATION; LIVER CIRCULATION; METABOLISM; REVIEW; TIME;

BILE ACIDS AND SALTS; CHOLESTEROL; CHOLESTYRAMINE; HYPERCHOLESTEROLEMIA; ILEUM; LIGATION; LIVER CIRCULATION; TIME FACTORS;

EID: 0015416425     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1972.03650040162015     Document Type: Article

References (76)

1. Siperstein MD, Nichols CW Jr, Chaikoff IL: Effects of ferric chloride and bile on plasma cholesterol and atherosclerosis in cholesterol-fed bird. Science 117:386-389, 1953.
2. Tennent DM, Siegel H, Zanetti ME, et al: Plasma cholesterol lowering action of bile acids binding polymers in experimental animals. J Lipid Res 1:469-473, 1960.
3. Buchwald H: Lowering of cholesterol absorption and blood levels by ileal exclusion: Experimental basis and preliminary clinical report. Circulation 29:713-720, 1964.
4. Baker RD, Searle GW: Bile salts absorption at various levels of rat small intestine. Proc Soc Exp Biol 105:521-523, 1960.
5. Borgström B, Lundh G, Hofmann A: The site of absorption of conjugated bile salts in man. Gastroenterology 45:229-238, 1963.
6. Lack L, Wiener IM: Intestinal absorption of bile salts and some biological implications. Fed Proc 22:1334-1338, 1963.
7. Holt PR: Intestinal absorption of bile acids in the rat. Am J Physiol 207:1-7, 1964.
8. Grundy SM, Ahrens EH Jr, Miettinen TA: Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids. J Lipid Res 6:397-410, 1965.
9. Grundy SM, Ahrens EH Jr: Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods. J Lipid Res 10:91-107, 1969.
10. Grundy SM, Ahrens EH Jr, Salen G: Interruption of the enterohepatic circulation of bile acids in man: Comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med 78:94-121, 1971.
11. Moore RB, Anderson JT, Taylor HL, et al: Effect of dietary fat on the fecal excretion of cholesterol and its degradation products in man. J Clin Invest 47:1517-1534, 1968.
12. Hashim SA, Van Itallie TB: Cholestyramine resin therapy for hypercholesteremia. JAMA 192:289-293, 1965.
13. Moore RB, Crane CA, Frantz ID: Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-414C and its degradation products in a hypercholesterolemic patient. J Clin Invest 47:1664-1671, 1968.
14. Moutafis CD, Myant NB, Tabaqehali S: The metabolism of cholesterol after resection or by-pass of the lower small intestine. Clin Sci 35:534-545, 1968.
15. Moutafis CD, Myant NB: The metabolism of cholesterol in two hypercholesterolemic patients treated with cholestyramine. Clin Sci 37:443-454, 1969.
16. Moore RB, Frantz ID Jr, Buchwald H: Changes in cholesterol pool size, turnover rate, and fecal bile acid and sterol excretion after partial ileal by-pass in hypercholesterolemic patients. Surgery 65:98-108, 1969.
17. Miettinen TA: Fecal steroid excretion and serum methyl sterols during cholestyramine treatment. Scand J Clin Lab Invest 23(suppl 108):56, 1969.
18. Miettinen TA, Lempinen M: Ileal by-pass operation in familial hypercholesterolemia. Scand J Clin Lab Invest 25(suppl 113):55, 1970.
19. Bergström S, Danielson H: On the regulation of bile acid formation in the rat liver. Acta Physiol Scand 43:1-7, 1958.
20. Grundy SM, Hofmann AF, Davignon J, et al: Human cholesterol synthesis is regulated by bile acids. J Clin Invest 45:1018, 1966.
21. Shefer S, Hauser S, Bekersky I, et al: Feedback regulation of bile acid biosynthesis in the rat. J Lipid Res 10:646-655, 1969.
22. Miettinen TA, Pelkonen R, Nikkilä EA, et al: Low excretion of fecal bile acids in a family with hypercholesterolemia. Acta Medica Scand 182:645-650, 1967.
23. Kottke BA: Differences in bile acid excretion: Primary hypercholesterolemia compared to combined hypercholesterolemia and hypertriglyceridemia. Circulation 40:13-20, 1969.
24. Miettinen TA: Sterol balance in hypercholesterolemia. Scand J Clin Lab Invest 24(suppl 110):48-51, 1969.
25. Buchwald H: The effect of ileal by-pass on atherosclerosis and hypercholesterolemia for the rabbit. Surgery 58:22-36, 1965.
26. Simmonds WJ, Hofmann AF, Theodor E: Absorption of cholesterol from a micellar solution: Intestinal perfusion studies in man. J Clin Invest 46:874-890, 1967.
27. Siperstein MD, Chaikoff IL, Reinhardt WO: C14-cholesterol: V. Obligatory function of bile in intestinal absorption of cholesterol. J Biol Chem 198:111-114, 1952.
28. Grundy SM, Ahrens EH Jr: An evaluation of the relative merits of two methods for measuring the balance of sterols in man: Isotope balance vs chromatographic analysis. J Clin Invest 9:1503-1515, 1966.
29. Goodman DS, Noble RP: Turnover of plasma cholesterol in man. J Clin Invest 47:231-241, 1968.
30. Hotta S, Chaikoff IL: The role of the liver in the turnover of plasma cholesterol. Arch Biochem 56:28-37, 1955.
31. Dietschy JM, Wilson JD: Cholesterol synthesis in the gastrointestinal tract: Localization and mechanisms of control. J Clin Invest 44:1311-1327, 1965.
32. Dietschy JM, Wilson JD: Cholesterol synthesis in the squirrel monkey: Relative rates of synthesis in various tissues and mechanisms of control. J Clin Invest 47:166-174, 1968.
33. Dietschy JM: The role of bile salts in controlling the rate of intestinal cholesterogenesis. J Clin Invest 47:286-300, 1968.
34. Dietschy JM, Wilson JD: Regulation of cholesterol metabolism. New Eng J Med 282:1128-1138, 1970.
35. Dietschy JM, Weis HJ: Cholesterol synthesis in the gastrointestinal tract. Amer J Clin Nutr 24:70-76, 1971.
36. Dietschy JM, Gamel WG: Cholesterol synthesis in the intestine of man: Regional differences and control mechanisms. J Clin Invest 50:827-880, 1971.
37. Huff JW, Gilfillan JL, Hunt VN: Effect of cholestyramine, a bile acid-binding polymer on plasma cholesterol and fecal bile acid excretion in the rat. Proc Soc Exp Biol 114:352-355, 1963.
38. Beher WT, Beher ME, Rao B: Bile acid and cholesterol metabolism in the mouse as affected by cholestyramine. Proc Soc Biol 122:881-884, 1966.
39. Schneider DL, Gallo DG, Sareet HP: Effect of cholestyramine on cholesterol metabolism in young adult swine. Proc Soc Exp Biol 121:1244-1248, 1966.
40. Moutafis CD, Myant NB: Increased hepatic synthesis of cholesterol after ileal by-pass in monkeys. Clin Sci 34:541-548, 1968.
41. Weis HJ, Dietschy JM: Failure of bile acids to control hepatic cholesterogenesis: Evidence for endogenous cholesterol feedback. J Clin Invest 48:2398-2408, 1969.
42. Fimognari GM, Rodwell VM: Cholesterol biosynthesis: Mevalonate synthesis inhibited by bile salts. Science 147:1038, 1965.
43. Back P, Hamprecht B, Lynen F: Regulation of cholesterol biosynthesis in rat liver: Diurnal changes of activity and influence of bile acids. Arch Biochem Biophys 133:11-21, 1969.
44. Berkowitz D: Selective blood lipid reductions by newer pharmacological agents. Amer J Cardiol 12:834-840, 1963.
45. Blacket RB, Woodhill J, Brown WD: The effect of cholestyramine (“MK 135”) on the serum cholesterol level in man. Med J Aust 2:15-18, 1964.
46. Gherondache CN, Pincus G: Metabolic changes induced in elderly patients with a cholesterol lowering resin, cholestyramine. Metabolism 13:1462-1468, 1964.
47. Howard RP, Brusco CJ, Furman RH: Effect of cholestyramine administration of serum lipids and on nitrogen balance in familial hypercholesterolemia. J Lab Clin Med 68:12-20, 1966.
48. Bressler R, Nowlin J, Bogdonoff MD: Treatment of hypercholesterolemia and hypertriglyceridemia by anion exchange resin. Southern Med J 59:1097-1103, 1966.
49. Danhof IE: The effect of cholestyramine on fecal excretion of ingested radioiodinated lipids. Amer J Clin Nutr 18:343-349, 1966.
50. Casdorph HR: Hypercholesteremia—treatment with cholestyramine, a bile acid sequestering resin. Calif Med 106:293-295, 1967.
51. Fallon HJ, Woods JW: Response of hyperlipoproteinemia to cholestyramine resin. JAMA 204:1161-1164, 1968.
52. Buchwald H, Moore RB, Lee GB, et al: Treatment of hypercholesterolemia: Combined dietary, surgical, and bile salt-binding resin therapy. Arch Surg 97:275-282, 1968.
53. Buchwald H, Varco RL: Partial ileal by-pass for hypercholesterolemia and atherosclerosis. Surg Gynec Obstet 124:1231-1238, 1967.
54. Swan DM, McGowan JM: Ileal by-pass in hypercholesterolemia associated with coronary heart disease. Amer J Surg 116:22-27, 1968.
55. Buchwald H, Moore RB, Frantz ID, et al: Cholesterol reduction by partial ileal by-pass in a pediatric population. Surgery 68:1101-1111, 1970.
56. Connor WE: Measures to reduce the serum lipid levels in coronary heart disease. Med Clin N Amer 52:1249-1260, 1968.
57. Khachadurian AK: Cholestyramine therapy in patients homozygous for familial hypercholesterolemia: Familial hypercholesterolemic xanthomatosis. J Atheroscler Res 8:177-188, 1968.
58. Johnston IDA, Davis JA, Moutafis CD, et al: Ileal by-pass in management of familial hypercholesterolemia. Proc Roy Soc Med 60:746-748, 1967.
59. Wilson JD, Reinke RT: Transfer of locally synthesized cholesterol from intestinal wall to intestinal lymph. J Lipid Res 9:85-92, 1968.
60. Knittle JL, Ahrens EH Jr: Carbohydrate metabolism in two forms of hyperglyceridemia. J Clin Invest 43:485-495, 1964.
61. Levy RI, Langer T: Hypolipidemic drugs and lipoprotein metabolism, in Fourth International Symposium on Drugs Affecting Lipid Metabolism. New York, Academic Press, to be published.
62. Pertsemlidis D, Ahrens EH Jr: The abnormal economy of cholesterol in the bile-fistula dog. Surg Forum 19:310-312, 1968.
63. Pertsemlidis D, Ahrens EH Jr: Effects of bile diversion on cholesterol biosynthesis in dogs. Bull NY Acad Med 45:105, 1969.
64. Kirchman EH, Pertsemlidis D, Ahrens EH Jr, et al: Total body cholesterol content and distribution in dogs: Effects of bile diversion and cholesterol feeding. Surg Forum 21:403-404, 1970.
65. Buchwald H: Ileal by-pass in the treatment of hyperlipidemia. J Atheroscler Res 10:1-4, 1969.
66. Hofmann AF, Poley JR: Cholestyramine treatment of diarrhea associated with ileal resection. New Eng J Med 281:397-402, 1969.
67. Vlahcevic ZR, Bell CC, Buhoc I, et al: Diminished bile acid pool size in patients with gallstones. Gastroenterology 59:165-173, 1970.
68. Danzinger RG, Hofmann AF, Schoenfield LJ, et al: Altered bile acid metabolism in patients with cholesterol cholelithiasis. J Clin Invest 50:24a, 1971.
69. Grundy SM, Metzger AL: A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology 62:1200-1217, 1972.
70. Grundy SM, Metzger AL, Adler R: Defective bile salt synthesis as cause of cholesterol gallstones. J Clin Invest 51:39a, 1972.
71. Heaton KW, Read AE: Association of gallstones and disorders of terminal ileum. Gut 10:414, 1969.
72. Kenney TJ, Garbutt JT: Effect of cholestyramine on bile acid metabolism in normal man. Gastroenterology 58:966, 1970.
73. Quintao E, Grundy SM, Ahrens EH Jr: Effects of dietary cholesterol on the regulation of total body cholesterol. J Lipid Res 12:233-247, 1971.
74. Sarles H, Crotte C, Gerolami A, et al: Influence of cholestyramine, bile salt, and cholesterol feeding on the lipid composition of hepatic bile in man. Scand J Gastroent 5:603-608, 1970.
75. Dam H, Prange I, Jensen MK, et al: Studies on human bile: V. Influence of cholestyramine treatment on the composition of bile in healthy subjects. Z Ernährungswiss 10:188-197, 1971.
76. Grundy SM, et al: Mechanism of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. J Lipid Research 13:531-551, 1972.